Clinical Trial Update: VP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell Transplant For NHL [NA]

View source ↗

Summary

This completed clinical trial evaluated VP and G-CSF with or without Rituximab as part of autologous peripheral stem cell transplantation for non-Hodgkin lympho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• G-CSF (granulocyte colony-stimulating factor)
• Rituximab (rituximab)
• VP

Snippet

Sponsor: The Cleveland Clinic | Conditions: Lymphoma | NA | Status: COMPLETED